These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22104541)

  • 41. Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.
    Stella GM; Luisetti M; Pozzi E; Comoglio PM
    Lancet Respir Med; 2013 May; 1(3):251-61. PubMed ID: 24429131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How Targeted Therapies Are Changing Treatment for Non-Small Cell Lung Cancer.
    Becze E
    ONS Connect; 2016 Feb; 31(2):24-5. PubMed ID: 26930998
    [No Abstract]   [Full Text] [Related]  

  • 43. Current Landscape of Targeted Therapy in Lung Cancer.
    Mayekar MK; Bivona TG
    Clin Pharmacol Ther; 2017 Nov; 102(5):757-764. PubMed ID: 28786099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticancer drugs: Finding the perfect combination.
    Flemming A
    Nat Rev Drug Discov; 2015 Jan; 14(1):13. PubMed ID: 25549585
    [No Abstract]   [Full Text] [Related]  

  • 45. [Molecular therapy in lung cancer].
    Gautschi O; Betticher DC
    Ther Umsch; 2004 Jun; 61(6):365-71. PubMed ID: 15253161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted therapy for solid tumors: current status.
    Zureikat AH; McKee MD
    Surg Oncol Clin N Am; 2008 Apr; 17(2):279-301, vii-viii. PubMed ID: 18375353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical year in review I: lung cancer, interventional pulmonology, noninvasive mask ventilation, and pulmonary vascular disease.
    Trow TK
    Proc Am Thorac Soc; 2005; 2(2):102-4. PubMed ID: 16113476
    [No Abstract]   [Full Text] [Related]  

  • 48. Intracellular signals of lung cancer cells as possible therapeutic targets.
    Tanaka K; Kumano K; Ueno H
    Cancer Sci; 2015 May; 106(5):489-96. PubMed ID: 25707772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New skin cancer target could delay drug resistance.
    Oncology (Williston Park); 2013 Mar; 27(3):164. PubMed ID: 23687783
    [No Abstract]   [Full Text] [Related]  

  • 50. Personalized lung cancer treatment based on molecular determinants.
    Simon GR
    J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
    [No Abstract]   [Full Text] [Related]  

  • 51. Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine.
    Dumur CI; Idowu MO; Powers CN
    Cancer Cytopathol; 2013 Feb; 121(2):61-71. PubMed ID: 22887782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer.
    Passiglia F; Caparica R; Giovannetti E; Giallombardo M; Listi A; Diana P; Cirrincione G; Caglevic C; Raez LE; Russo A; Rolfo C
    Expert Opin Investig Drugs; 2016; 25(4):385-92. PubMed ID: 26881293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic lethal vulnerabilities of cancer.
    Fece de la Cruz F; Gapp BV; Nijman SM
    Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Targeted agents in the treatment of lung cancer].
    Staudacher L; Teixeira L; Kempf E; Rousseau-Bussac G; Jouveshomme S; Cohen R; Beuzelin C; Jagot JL; Salmeron S; Trédaniel J
    Pathol Biol (Paris); 2012 Aug; 60(4):246-53. PubMed ID: 22743094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanisms of resistance to target therapy].
    Matsusaka S
    Nihon Rinsho; 2012 Dec; 70(12):2195-8. PubMed ID: 23259396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy].
    Zhang G; Wang H; Zhang M; Li P; Ma Z
    Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):587-91. PubMed ID: 26383984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting signaling pathways in lung cancer therapy.
    Cho WC
    Expert Opin Ther Targets; 2013 Feb; 17(2):107-11. PubMed ID: 23231077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scientists develop new tool for targeted cancer drug development.
    Printz C
    Cancer; 2012 Jun; 118(12):3001. PubMed ID: 22674499
    [No Abstract]   [Full Text] [Related]  

  • 59. Advances in targeting signal transduction pathways.
    McCubrey JA; Steelman LS; Chappell WH; Sun L; Davis NM; Abrams SL; Franklin RA; Cocco L; Evangelisti C; Chiarini F; Martelli AM; Libra M; Candido S; Ligresti G; Malaponte G; Mazzarino MC; Fagone P; Donia M; Nicoletti F; Polesel J; Talamini R; Bäsecke J; Mijatovic S; Maksimovic-Ivanic D; Michele M; Tafuri A; Dulińska-Litewka J; Laidler P; D'Assoro AB; Drobot L; Umezawa D; Montalto G; Cervello M; Demidenko ZN
    Oncotarget; 2012 Dec; 3(12):1505-21. PubMed ID: 23455493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Summary report from the 13(th) Annual Targeted Therapies of the Treatment of Lung Cancer Meeting.
    Morgensztern D; Govindan R
    Clin Lung Cancer; 2014 Jan; 15(1):16-20. PubMed ID: 24377742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.